Valeant Pharmaceuticals International, Inc. (T.VRX) hit a new 52-week high of $53.38 Monday. Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga™ (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older
March Networks Corporation (T.MN) hit a new 52-week high of $5.38 Monday. No news announcements today.
Gold Reserve Inc. (T.GRZ) hit a new 52-week high of $2.83 Monday. No news announcements today.
Related Stories
